Discussions about the economic and quality benefits of oral solid dose continuous manufacturing for commercial drug products has been front and center within the pharma industry. Leveraging continuous manufacturing in development can allow greater assurance of quality as well as scale up efficiencies. During this session, learn how continuous manufacturing can help:

  • Reduce API use
  • Provide robust, simplified formulation
  • Create scale up efficiencies
  • Enhance speed to clinic
  • Provide greater assurance of quality

Featured Speaker

Keirnan LaMarche, Ph.D.

Senior Principal Scientist
Thermo Fisher Scientific

Dr. Keirnan LaMarche is an expert in solid dosage form design, continuous manufacturing, and is especially knowledgeable on the subjects of powder flow and tablet compaction. Keirnan received his PhD in chemical Engineering from Rutgers University in 2008. He gained 10 years of experience in solid dosage form development at Bristol-Myers Squibb. He joined Thermo Fisher Scientific as a Senior Principal Scientist in 2018 to build and lead the Continuous Manufacturing Development Group.

Date:  Wednesday, May 13, 2020
Time:  11am ET / 8am PT
Duration:  1 Hour

Register now for this webinar